DNA methylation profile to predict clinical outcome of anti-EGFR treatment in metastatic colorectal cancer

Authors :: Hidekazu Takahashi
Hiroyuki Aburatani
Hideki Shimodaira
Naoki Takahashi
Chikashi Ishioka
Kenji Tatsuno
Shingo Tsuji
Masanobu Takahashi
Yasuhide Yamada
Shin Takahashi
Kota Ouchi
Source :: Journal of Clinical Oncology. 33:e14574-e14574
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e14574 Background: For metastatic colorectal cancer (mCRC) treatment, anti-epidermal growth factor receptor (EGFR) treatment is one of the major options. However, there are few reliable biomarkers ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
integumentary system
business.industry
Colorectal cancer
medicine.disease
digestive system diseases
Growth factor receptor
Internal medicine
medicine
DNA Methylation Profile
business

Full Text Access

Tools